Fremanezumab for preventing migraine

Equality Impact Assessment (Guidance development) (PDF 167 KB)

Final draft guidance

Final appraisal document (PDF 351 KB)

Public committee slides (PDF 598 KB)

Committee papers (PDF 663 KB)

Final draft guidance: TA631

Committee papers (PDF 2.95 MB)

Final appraisal document (PDF 383 KB)

Public committee slides (PDF 1.03 MB)

Draft guidance: TA631

Appraisal consultation document (PDF version) (PDF 365 KB)

Committee papers (PDF 3.9 MB)

Public committee slides (PDF 839 KB)

Final scope (PDF 224 KB)

Draft scope and provisional stakeholder list comments table (post-referral) (PDF 601 KB)

Final stakeholder list (PDF 255 KB)

Draft scope post referral (PDF 318 KB)

Draft matrix post referral (PDF 255 KB)